The biology underpinning a rare genetic mutation that allows its carrier to live virtually pain-free, heal more rapidly and experience reduced anxiety and fear, has been uncovered by new research from UCL.
May 23, 2023
1
474
Mutations of a gene called Foxp2 have been linked to a type of speech disorder called apraxia that makes it difficult to produce sequences of sound. A new study from MIT and National Yang Ming Chiao Tung University sheds ...
May 4, 2023
0
40
No treatment currently exists that can stop the silent progression of multiple sclerosis, and many promising drugs have proved ineffective in clinical trials. To reduce this failure rate and better predict the potential of ...
May 3, 2023
0
30
Women are about twice as likely as men to be diagnosed with Alzheimer's disease. Some of that is age; in the U.S., women outlive men by five to six years, and advanced age is the strongest risk factor for Alzheimer's. But ...
May 2, 2023
0
20
Even mild concussion can cause long-lasting effects to the brain, according to researchers at the University of Cambridge. Using data from a Europe-wide study, the team has shown that for almost a half of all people who receive ...
Apr 25, 2023
0
79
In a study published in Nature Communications, a team led by Krembil Brain Institute at UHN Senior Scientists, Drs. Lorraine Kalia and Suneil Kalia, and University of Toronto (U of T) Professor, Dr. Philip M. Kim, has identified ...
Apr 19, 2023
0
65
QIMR Berghofer researchers are a step closer to solving what causes obsessive-compulsive disorder, after discovering changes in how distinct brain regions communicate. This important finding could guide the development of ...
Apr 18, 2023
0
9
Researchers at the UCL Queen Square Institute of Neurology have discovered a network of connections in the brain linked to seizures in people with epilepsy.
Apr 17, 2023
0
5
Recently, a team of South Korean scientists led by Director C. Justin Lee of the Center for Cognition and Sociality within the Institute for Basic Science made a discovery that could revolutionize both the diagnosis and treatment ...
Apr 17, 2023
0
38
Patients with "blinding" headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found.
Mar 13, 2023
0
44
